Plaintiffs in Fluoroquinolone Nerve Damage Cases Ask JPML to Create MDL Docket in Illinois
May 21, 2015
DOCUMENTS
- Motion
WASHINGTON, D.C. — Plaintiffs accusing the makers of fluoroquinolone products of failing to adequately warn that the prescription antibiotics may cause permanent nerve damage have asked the Judicial Panel on Multidistrict Litigation to create an MDL docket in the U.S. District Court for the Southern District of Illinois.
According to the May 19 motion, there are at least 24 substantially similar federal actions pending in 16 federal courts against Johnson & Johnson, Janssen Pharmaceuticals Inc., Bayer HealthCare Pharmaceuticals, Merck & Company Inc., Schering Corp. and McKesson Corp. The lawsuits involve the prescription antibiotics Avelox, Cipro and Levaquin.
In 2004, …
FIRM NAMES
- Baron & Budd
- Clifford Law Offices
- Heard Robins Cloud
UPCOMING CONFERENCES
HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference
January 10, 2025 - Long Beach, CA
The Westin Long Beach
HarrisMartin's New Jersey Asbestos Litigation Conference
February 27, 2025 - New Brunswick, NJ
Hyatt Regency New Brunswick